These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs. Powis G Cancer Treat Rev; 1982 Jun; 9(2):85-124. PubMed ID: 6181872 [No Abstract] [Full Text] [Related]
5. Pharmacokinetic drug interactions of commonly used anticancer drugs. Balis FM Clin Pharmacokinet; 1986; 11(3):223-35. PubMed ID: 2426030 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. Kirsch LE; Notari RE J Pharm Sci; 1984 Jun; 73(6):728-32. PubMed ID: 6204036 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Dedrick RL; Myers CE; Bungay PM; DeVita VT Cancer Treat Rep; 1978 Jan; 62(1):1-11. PubMed ID: 626987 [TBL] [Abstract][Full Text] [Related]
8. Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man. Powis G Drug Metab Rev; 1983; 14(6):1145-63. PubMed ID: 6373208 [TBL] [Abstract][Full Text] [Related]
10. Selective uptake and retention of anticancer agents by sensitive cells. Hill DL; Montgomery JA Cancer Chemother Pharmacol; 1980; 4(4):221-5. PubMed ID: 6449312 [TBL] [Abstract][Full Text] [Related]
11. Comparison of transport of chemotherapeutic drugs in voxelized heterogeneous model of human brain tumor. Bhandari A; Bansal A; Singh A; Gupta RK; Sinha N Microvasc Res; 2019 Jul; 124():76-90. PubMed ID: 30923021 [TBL] [Abstract][Full Text] [Related]
12. Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy. Bischoff KB Cancer Chemother Rep; 1975; 59(4):777-93. PubMed ID: 1175169 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic considerations on resistance to anticancer drugs. Dedrick RL; Zaharko DS; Bender RA; Bleyer WA; Lutz RJ Cancer Chemother Rep; 1975; 59(4):795-804. PubMed ID: 1236771 [TBL] [Abstract][Full Text] [Related]
14. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC. Takenaka T; Kimura K Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907 [No Abstract] [Full Text] [Related]
18. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Chen HS; Gross JF Cancer Treat Rep; 1980 Jan; 64(1):31-40. PubMed ID: 6155210 [TBL] [Abstract][Full Text] [Related]
19. Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexate. Goldman D; Bowen D; Gewirtz DA Cancer Treat Rep; 1981; 65 Suppl 3():43-56. PubMed ID: 6179615 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics use in anti-cancer therapy (author's transl)]. Gisselbrecht C; Marty M; Boiron M Sem Hop; 1978 Nov 18-25; 54(41-42):1261-4. PubMed ID: 216104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]